Bath & Body Works (BBWI) shares plummeted 25% due to disappointing Q3 financials and a forecasted high-single-digit revenue decline in Q4. Stock is down 60% from its peak. New CEO’s “Consumer First Formula” aims to save $250 million, refocus on core products, and exit non-core segments. Shares may be a turnaround play with 6x forward earnings, $650 million expected free cash flow, and favorable analyst ratings predicting a 130% potential upside to $35 target price.

Read more at Yahoo Finance: Should You Buy the Post-Earnings Dip in Bath & Body Works Stock?